insights_auto
Why is CTVA up 2.41%?
Dive Deeperchevron_right
CTVA:NYSE
Corteva Inc
$11.92
arrow_upward
+2.41%(+0.28) 1D
$11.90
arrow_downward
-0.17% (-0.020)bedtimeAfter hours
Closed: Nov 2, 4:00:05 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CTVA...
Open
$11.61
High
$12.02
Low
$11.51
Mkt. cap
7.95B
Avg. vol.
27.58M
Volume
20.39M
Dividend
1.68%
Quarterly dividend
$0.05
P/E ratio
7.88
52-wk high
$14.62
52-wk low
$9.08
EPS
$1.51
Beta
0.57
Shares outstanding
667.30M
No. of employees
22K
Open
$11.61
High
$12.02
Low
$11.51
Mkt. cap
7.95B
Avg. vol.
27.58M
Volume
20.39M
Dividend
1.68%
Quarterly dividend
$0.05
P/E ratio
7.88
52-wk high
$14.62
52-wk low
$9.08
EPS
$1.51
Beta
0.57
Shares outstanding
667.30M
No. of employees
22K
News stories
From web sources and news partners
Foreign Policy Journal
·
35 minutes ago
RTX Corporation's (NYSE: RTX) $271 Billion Backlog Fuels Analyst Optimism Despite Engine Concerns
Dealroom
·
39 minutes ago
Agility Robotics clears SPAC vote, expects $465M and Nasdaq debut November 5
investingLive
·
8 minutes ago
JPMorgan’s four midterm scenarios: S&P 500 seen moving between -0.25% and +1.25%
Bloomberg.com
·
4 hours ago
Nasdaq 100 Enters Correction as Megacap Results Amplify AI Fears
Profile
Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International. Wikipedia
About Corteva Inc
Analyst ratings
Based on 14 analysts giving stock ratings to CTVA in the past 3 months
Strong buy
Buy
12
Hold
2
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CTVA in the last 3 months.
Highest
Current $11.92
$101.00 (+747.32%)
Average
$46.54 (+290.44%)
Lowest
$15.00 (+25.84%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Arun Viswanathan RBC Capital | Buy | Maintained | $17.00 | +42.6% | 10/14/2026 |
Lucas Beaumont UBS | Hold | Maintained | $15.00 | +25.8% | 10/12/2026 |
Salvator Tiano KeyBanc | Buy | Upgraded | $17.00 | +42.6% | 10/07/2026 |
Edlain Rodriguez Mizuho Securities | Buy | Maintained | $16.00 | +34.2% | 10/06/2026 |
Jeffrey Zekauskas J.P. Morgan | Buy | Upgraded | $19.00 | +59.4% | 10/06/2026 |
Matthew DeYoe Bank of America Securities | Buy | Maintained | - | - | 10/05/2026 |
Kristen Owen Oppenheimer | Buy | Reiterated | $17.00 | +42.6% | 10/05/2026 |
Joel Jackson BMO Capital | Buy | Maintained | $15.00 | +25.8% | 10/02/2026 |
Vincent Andrews Morgan Stanley | Buy | Maintained | $18.00 | +51% | 10/02/2026 |
Joshua Spector UBS | Hold | Reiterated | $90.00 | +655% | 10/01/2026 |
Alexandra Yates Argus Research | Buy | Maintained | $91.00 | +663.4% | 09/17/2026 |
Patrick Cunningham Citi | Hold | Maintained | $91.00 | +663.4% | 09/17/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $97.00 | +713.8% | 09/16/2026 |
Benjamin Theurer Barclays | Buy | Maintained | $91.00 | +663.4% | 09/16/2026 |
Unknown Analyst KeyBanc | Hold | Initiated | - | - | 09/11/2026 |
John McNulty BMO Capital | Buy | Maintained | $100.00 | +738.9% | 08/17/2026 |
David Begleiter Deutsche Bank | Buy | Reiterated | $101.00 | +747.3% | 08/03/2026 |
Duffy Fischer Goldman Sachs | Buy | Maintained | $96.00 | +705.4% | 08/02/2026 |
Michael Sison Wells Fargo | Buy | Reiterated | $90.00 | +655% | 05/27/2026 |
Unknown Analyst Berenberg Bank | Hold | Reiterated | $78.00 | +554.4% | 03/26/2026 |
Aleksey Yefremov KeyBanc | Hold | Maintained | - | - | 02/05/2026 |
Next call in 9 days
Thu, Nov 12, 9:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.11
Revenue / Est. (USD)
- / 1.77B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Mar 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
Revenue | 4.42B | 1.88B | 1.85B |
Cost of goods sold | 2.34B | 1.06B | 1.11B |
Cost of revenue | 2.34B | 1.06B | 1.11B |
Research and development expenses | 335.00M | 102.00M | 122.00M |
Total research and development expenses | - | - | - |
Selling, general, and admin expenses | 751.00M | 337.00M | 346.00M |
Operating expense | 1.21B | 493.00M | 497.00M |
Total operating expenses | 3.55B | 1.56B | 1.61B |
Operating income | 869.00M | 325.00M | 236.00M |
Other non operating income | - | - | - |
EBT including unusual items | 784.00M | 227.00M | 144.00M |
EBT excluding unusual items | 806.00M | 291.00M | 191.00M |
Income tax expense | 117.00M | 22.00M | -19.00M |
Effective tax rate | 14.92% | 9.69% | -13.19% |
Other operating expenses | -42.00M | 15.00M | -10.00M |
Net income | 652.00M | 203.00M | 160.00M |
Net profit margin | 14.76% | 10.79% | 8.66% |
Earnings per share | - | - | - |
Interest and investment income | - | - | - |
Interest expense | -36.00M | -34.00M | -45.00M |
Net interest expenses | -36.00M | -34.00M | -45.00M |
Depreciation and amortization charges | - | - | - |
EBITDA | 1.16B | 622.00M | 533.00M |
Gain or loss from assets sale | -4.00M | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events